Patents by Inventor Frederic Dessauge

Frederic Dessauge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES BINDING THE PHOSPHATASE 2A PROTEIN
    Publication number: 20100009909
    Abstract: The invention relates to novel synthetic or natural E4orf4 or Bcl-2 peptides particularly useful in antitumoral, antiviral and antiparasitic treatments, said peptides being less than 30 amino acids long and binding in vitro to a phosphatase 2A protein holoenzyme or one of its subunits. The invention also relates to polynucleotides encoding the novel peptides, vectors expressing same, as well as antibodies identifying same and probes identifying transcripts thereof.
    Type: Application
    Filed: January 12, 2009
    Publication date: January 14, 2010
    Applicant: INSTITUT PASTEUR
    Inventors: Alphonse Garcia, Frederic Dessauge, Xavier Cayla, Angelita Rebollo
  • Peptides binding to the phosphatase 2A protein
    Patent number: 7498306
    Abstract: The invention relates to novel synthetic or natural E4orf4 or Bcl-2 peptides particularly useful in antitumoral, antiviral and antiparasitic treatments, said peptides being less than 30 amino acids long and binding in vitro to a phosphatase 2A protein holoenzyme or one of its subunits. The invention also relates to polynucleotides encoding the novel peptides, vectors expressing same, as well as antibodies identifying same and probes identifying transcripts thereof.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: March 3, 2009
    Assignee: Institut Pasteur
    Inventors: Alphonse Garcia, Frederic Dessauge, Xavier Cayla, Angelita Rebollo
  • Peptides binding the phosphatase 2A protein and polynucleotides encoding same
    Publication number: 20070065410
    Abstract: The invention relates to novel synthetic or natural E4orf4 or Bcl-2 peptides particularly useful in antitumoral, antiviral and antiparasitic treatments, said peptides being less than 30 amino acids long and binding in vitro to a phosphatase 2A protein holoenzyme or one of its subunits. The invention also relates to polynucleotides encoding the novel peptides, vectors expressing same, as well as antibodies identifying same and probes identifying transcripts thereof.
    Type: Application
    Filed: April 18, 2005
    Publication date: March 22, 2007
    Applicant: INSTITUT PASTEUR
    Inventors: Alphonse Garcia, Frederic Dessauge, Xavier Cayla, Angelita Rebollo